Graphite Bio, Inc.

NASDAQ:GRPH

3.18 (USD) • At close March 21, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Revenue 000000
Cost of Revenue 02.4078.3460.7340.1210
Gross Profit 0-2.407-8.346-0.734-0.1210
Gross Profit Ratio 000000
Reseach & Development Expenses 29.80129.7372.78737.9329.1230
General & Administrative Expenses 040.97332.85222.5114.3770.029
Selling & Marketing Expenses 000000
SG&A 28.80940.97332.85222.5114.3770.029
Other Expenses 062.0810-10.317-54.8330
Operating Expenses 58.6170.703105.63960.44313.50.029
Operating Income -58.61-73.11-105.639-60.443-13.5-0.029
Operating Income Ratio 000000
Total Other Income Expenses Net 8.842-51.5414.587-10.317-54.873-0.08
Income Before Tax -49.768-124.651-101.052-70.76-68.373-0.109
Income Before Tax Ratio 000000
Income Tax Expense 0.0010-4.587-11.051-54.7930.08
Net Income -49.769-124.651-96.465-59.709-13.58-0.189
Net Income Ratio 000000
EPS -2.34-15.3-12.31-14.45-2.78-0.09
EPS Diluted -2.34-15.3-12.31-14.45-2.78-0.09
EBITDA -58.61-70.703-105.639-59.709-13.379-0.029
EBITDA Ratio 000000